AI Prospecting for Johnson & Johnson
Company data:
Company size:
131900 employeesWebsite URL:
https://www.jnj.comIndustry
Pharmaceuticals, Medical Devices, Consumer HealthHeadquarters:
New Brunswick, New Jersey, USAInvestment round:
Publicly Traded (NYSE: JNJ)ARR:
$93 billionLatest news about Johnson & Johnson
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Johnson & Johnson reported a 2.4% increase in Q1 2025 sales to $21.9 billion, with operational growth of 4.2% and adjusted operational growth of 3.3%. Net earnings rose to $10.999 million, and EPS increased to $4.54. The company also announced a 4.8% dividend increase to $1.30 per share, marking its 63rd consecutive year of dividend increases[2][3][4].
Johnson & Johnson announced the completion of its acquisition of Intra-Cellular Therapies, enhancing its neuroscience portfolio with the addition of CAPLYTA. The company also reported significant pipeline progress, including the approval of TREMFYA for Crohn’s disease and advancements in RYBREVANT/LAZCLUZE for non-small cell lung cancer and OTTAVA, a soft tissue surgical robotic system[1][3].
Johnson & Johnson announced the completion of its first cases with OTTAVA™, a soft tissue surgical robotic system, marking a significant milestone in its MedTech innovations[4].
Open job positions at Johnson & Johnson
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Principal R&D Software Engineer - Shockwave
Digital Marketing Manager, Global Strategic Marketing (Irvine, CA) Aesthetics and Reconstruction
Principal R&D Software Engineer - Shockwave
